All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Borderline Personality Disorder (BPD) is the most common personality disorder, affecting about 0.5 to 5.9% of the general population \[[@pone.0143994.ref001]\]. One of the most characteristic and common symptoms in BPD is the presence of non-suicidal self-injury (NSSI) behaviors \[[@pone.0143994.ref002]\], which refers to the deliberate, self-inflicted destruction of body tissue without suicidal intent, and for purposes not socially sanctioned (*e*.*g*. tattoos or piercings) \[[@pone.0143994.ref003],[@pone.0143994.ref004]\]. Because NSSI behaviors are a public health concern \[[@pone.0143994.ref005]\], they have become a new clinical entity in the new DSM-5 \[[@pone.0143994.ref006]\], in contrast to DSM-IV-TR \[[@pone.0143994.ref007]\], in which they were only restricted to the BPD. Despite growing scientific interest, little is known about the reason why people engage in a direct form of self-injury against the innate fight for self-preservation \[[@pone.0143994.ref008]\].

BPD patients usually carry out NSSI behaviors during states of emotional stress as a maladaptive attempt to self-regulate \[[@pone.0143994.ref009]--[@pone.0143994.ref011]\]. It has been proposed that these behaviors might be explained by a failure in the executive functioning involved in emotion regulation and cognitive control \[[@pone.0143994.ref012],[@pone.0143994.ref013]\]. Dysfunction in executive processing might be at the core of some of the BPD symptoms, especially impulsivity and emotion regulation among others \[[@pone.0143994.ref014]\], and it has also been related with NSSI beyond the BPD \[[@pone.0143994.ref015]\].

One of the most important subcomponents of cognitive control is the capacity to monitor errors and conflicts associated with the performance of certain actions (also referred to as 'response monitoring' or 'performance monitoring') \[[@pone.0143994.ref016]\]. A well-known electrophysiological signature of these functions is the Error-Related Negativity (ERN, also known as Ne) \[[@pone.0143994.ref017],[@pone.0143994.ref018]\], an Event-Related Potential (ERP) which appears after the execution of an error in a speeded-up action-selection task. The ERN peaks 60--80 ms after the erroneous response and shows a frontocentral scalp distribution consistent with a neural source in the Anterior Cingulate Cortex (ACC) \[[@pone.0143994.ref019]\]. While first accounts interpreted this component as an error execution index \[[@pone.0143994.ref018]\], recent theories have related it to different functions such as conflict detection \[[@pone.0143994.ref020]\] or reinforcement-learning teaching signals indexing worse than expected events \[[@pone.0143994.ref021]\]. In addition, another ERP component, the so-called error positivity Pe, appears around 300 ms after the execution of an error \[[@pone.0143994.ref022]\]. This ERP component shows a centro-parietal topography and has been related to error awareness \[[@pone.0143994.ref023],[@pone.0143994.ref024]\].

Error-processing dysfunctions have been reported in a variety of mental disorders when compared with healthy controls (for a review: \[[@pone.0143994.ref025]\] and \[[@pone.0143994.ref026]\]). In BPD, this alteration is manifested by an increase in the reaction time (RT) of erroneous responses compared to correct ones and attenuated ERN \[[@pone.0143994.ref027]\], but not Pe amplitude \[[@pone.0143994.ref028]\]. In these patients reduced ERN amplitude has been related to self-reported impulsivity \[[@pone.0143994.ref028]\]. Surprisingly, no previous studies have investigated ERP error monitoring signatures associated with NSSI behaviors despite their relationship with executive functions. Thus, NSSI acts are impulsive \[[@pone.0143994.ref029],[@pone.0143994.ref030]\] and repetitive maladaptive coping responses to stressful situations \[[@pone.0143994.ref004]\], which suppose a non-optimal response to outcomes \[[@pone.0143994.ref031]\]. Due to overlapping between NSSI and BPD (69--90% of BPD patients engaged in NSSI) \[[@pone.0143994.ref032]\], it is difficult to establish to what extent the impairment in error monitoring found in previous BPD studies \[[@pone.0143994.ref027],[@pone.0143994.ref028]\] is specific to this disorder or, in contrast, is related to NSSI.

The goal of the present study was to determine the impairment of error monitoring and cognitive control in BPD patients according to their tendency to engage in NSSI behaviors. Following previous studies we hypothesized that BPD patients (when compared to healthy controls) would present a reduced ERN after error execution indicating impairment in cognitive control \[[@pone.0143994.ref027],[@pone.0143994.ref028]\]. In addition, we hypothesized those BPD patients with NSSI history would show a larger reduction in ERN and Pe components compared to those without it, thus indicating a more severe impairment in the cognitive control system.

Materials and Methods {#sec006}
=====================

Participants {#sec007}
------------

All procedures were approved by the Clinical Research Ethics Committee of the Bellvitge University Hospital and the study was conducted in accordance with the Declaration of Helsinki. An information sheet about the study was given to all patients and healthy controls. Participants were encouraged to discuss their possible participation with close people and take several days to decide it. Obtaining informed consent involved the following steps. First, a member of the research staff discussed the study with each of the potential participants ensuring that they understood the procedures, risks, and benefits as well as the fact that their participation was voluntary and their refusal would have no consequences. In this interview, participants were encouraged to ask any questions they might have. Based on this interview, only the subjects who had the mental faculties to consider their participation and their decision-making capacity intact were recruited to the study. Finally, written informed consent was obtained from all subjects who agreed to participate. Each participant freely signed the informed consent form.

Two groups of 17 BPD outpatients each were selected. All patients were women, and they were in treatment in the Mental Health Area of the Hospital of Igualada (Spain). [Table 1](#pone.0143994.t001){ref-type="table"} shows the demographical and clinical characteristics of these groups. The Diagnostic Interview for Borderlines-Revised (DIB-R) \[[@pone.0143994.ref033]\] was used twice with two independent trained clinicians each, in order to ensure the diagnosis (first: 7.85±1.21; second: 7.82±1.26; Intraclass Correlation Coefficient = .58). Both groups were created according to the presence or not of NSSI. Thus, we selected a BPD group (SI-BPD; N = 17) characterized by: a) lifetime history of five or more episodes of any NSSI behavior (determined by the Inventory of Statements About Self-injury, ISAS, see below), and b) two of these episodes occurred in the last two years (determined by the self-harm item of the DIB-R). In contrast, the BPD group without NSSI (NI-BPD; N = 17) was composed of BPD patients with no prior history of any NSSI behavior at the time of study enrollment (assessed by the ISAS and DIB-R). The NSSI typologies and frequency depicted in [Table 2](#pone.0143994.t002){ref-type="table"}. In addition, both groups were matched in sex, age and IQ ([Table 1](#pone.0143994.t001){ref-type="table"}). Finally, a third group of seventeen sex-, age-, and IQ-matched control women, were recruited by means of local advertising. These participants had no previous history or current mental disorder.

10.1371/journal.pone.0143994.t001

###### Demographic and Clinical Characteristics of BPD patients and Healthy control participants.

![](pone.0143994.t001){#pone.0143994.t001g}

                                                      NI-BPD (n = 17)   SI-BPD (n = 17)   Controls (n = 17)   Group differences                           
  --------------------------------------------------- ----------------- ----------------- ------------------- ------------------- ------- ------- ------- --------------------------------------------------------
  **Participants Characteristics**                                                                                                                        
  Age (years)                                         30.29             6.26              29.94               6.04                33.18   6.38    1.38    .261
  IQ                                                  101.08            10.06             94.96               8.19                99.52   8.68    2.12    .131
  Onset[^a^](#t001fn002){ref-type="table-fn"} (age)   27.06             5.01              25.47               5.21                                .79     .378
  **Clinical status**                                                                                                                                     
  BIS-11                                              69                17.52             76.25               17.28               41.23   15.11   20.46   **\< .001** [^**b**^](#t001fn003){ref-type="table-fn"}
  HDRS                                                10.06             5.87              13.06               3.68                                3.13    .087
  GAF                                                 56.04             7.98              47.96               6.84                                3.81    **\< .001**
  DIB-R                                               7.37              1.02              8.29                1.05                                6.48    **.016**
  CGI-BPD                                             4.51              1.41              5.65                0.99                                7.32    **.011**
  BSL-23                                              2.01              0.83              2.11                0.97                                .33     .73

Notes. *BIS-11*, Barratt Impulsiveness Scale-11; *HDRS*, Hamilton Depression Rating Scales; *GAF*, Global Assessment of Functioning (DSM-IV); *DIB-R*, Diagnostic Interview for Borderlines-Revised; *CGI-BPD*, Clinical Global Impression for the BPD; *BSL-23*, Borderline Symptom List 23.

^a^ Age at onset of any regular BPD treatment

^b^ SI-BPD = NI-NSSI, BPD \> Control.

Significant values were depicted in bold. *P*-values lower than .001 are indicated as \< .001.

10.1371/journal.pone.0143994.t002

###### Lifetime frequency of 12 NSSI behaviors assessed by the ISAS.

![](pone.0143994.t002){#pone.0143994.t002g}

               NSSI Behaviors                                                                                                                           
  ------------ ---------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  \<5          3 (17.6)         5 (29.4)    15 (88.2)   11 (64.7)   12 (70.6)   10 (58.8)   12 (70.6)   2 (11.8)    7 (41.2)    10 (58.8)   16 (94.1)   15 (88.2)
  5--50        6 (35.3)         7 (41.2)    1 (5.9)     4 (23.5)    3 (17.6)    3 (17.6)    3 (17.6)    9 (52.9)    4 (23.5)    3 (17.6)    1 (5.9)     1 (5.9)
  51--100      1 (5.9)          2 (11.8)    0           0           0           2 (11.8)    2 (11.8)    2 (11.8)    2 (11.8)    1 (5.9)     0           0
  101--250     2 (11.8)         1 (5.9)     1 (5.9)     0           0           0           0           1 (5.9)     2 (11.8)    2 (11.8)    0           0
  \>250        5 (29.4)         2 (11.8)    0           2 (11.8)    2 (11.8)    2 (11.8)    0           3 (17.6)    2 (11.8)    1 (5.9)     0           1 (5.9)
  Total \> 5   14 (82.4)        12 (70.6)   2 (11.8)    6 (35.3)    5 (29.4)    7 (41.2)    5 (29.4)    15 (88.2)   10 (58.8)   7 (41.2)    1 (5.9)     2 (11.8)

Notes. BPD subjects estimated the number of times they have engaged NSSI behaviors. The total score was grouped in different categories (from less than 5 times to more than 250 times). Additionally the lifetime frequency above 5 for each NSSI type was computed.

^a^ Rubbing skin against rough surfaces

^b^ Swallowing chemicals

All three groups were assessed with the Spanish version of the Structured Clinical Interview for DSM-IV Axis II Personality Disorders \[[@pone.0143994.ref034]\] and with DSM-IV Axis I interview \[[@pone.0143994.ref035]\]. BPD patients showed comorbidity with other personality disorders and Axis I disorders (for further information see Table B in [S1 File](#pone.0143994.s001){ref-type="supplementary-material"}). Finally, the presence of brain injury, psychotic, bipolar, current major depressive disorder or drug abuse and IQ below 80 were exclusion criteria.

Psychometric measures {#sec008}
---------------------

First, a Spanish version of the Inventory of statements about self-injury (ISAS) \[[@pone.0143994.ref036]\] was used to assess the lifetime frequency of 12 NSSI behaviors (*e*.*g*. cutting, burning or carving) and their descriptive and contextual factors (*e*.*g*. age of onset). This part of the ISAS shows good reliability and validity \[[@pone.0143994.ref037]\]. Those respondents who endorsed one or more NSSI behaviors were instructed to complete the second part of the ISAS, which assesses 13 potential functions of these NSSI behaviors (e.g. sensation seeking, affect regulation). Participants also completed the Borderline Symptom List (BSL-23) \[[@pone.0143994.ref038],[@pone.0143994.ref039]\], which evaluates the amount of suffering on a list of 23 problems during the last week (e.g., "It was hard for me to concentrate" or "I wanted to punish myself"). In addition, the CGI-BPD severity form scale, which is an adaptation of the Clinical Global Impression (CGI) scale designed to assess severity in BPD patients \[[@pone.0143994.ref040]\], was completed by the clinician. Finally, the Barratt Impulsiveness Scale (BIS-11) \[[@pone.0143994.ref041]\] was used to measure the impulsivity of the patients.

Medication load {#sec009}
---------------

A medication load protocol was used to determine the total medication load, as previously used in psychiatric population \[[@pone.0143994.ref042]\]. Anti-depressant, anxiolytic, mood stabilizer, and anti-psychotic medications were coded as absent = 0, low = 1, or high = 2 based on previously employed methods to convert each medication to a standardized dose \[[@pone.0143994.ref043],[@pone.0143994.ref044]\]. Anti-psychotics were converted into chlorpromazine dose equivalents \[[@pone.0143994.ref045]\]. As a result, a composite measure of total medication load was obtained.

Task {#sec010}
----

We applied a modified variant of the Eriksen Flanker task \[[@pone.0143994.ref046]\] that required the participants to respond, pressing the corresponding mouse button with the index or middle finger of their dominant hand, to the pointing direction (right or left) of a central arrow from an array of five arrows. All four surrounding arrows were either compatible or incompatible with the central arrow (same or different direction respectively), favoring performance errors in the incompatible condition \[[@pone.0143994.ref047],[@pone.0143994.ref048]\]. We presented 33.3% of compatible and 50% of incompatible trials. In the remaining 16.6%, we included no-go trials, following a variant of the stop-signal paradigm \[[@pone.0143994.ref049]\]. In these stop trials, the central green arrow changed to red after a variable delay, indicating that participants should inhibit their response. The delay was adapted to participants' behavior by means of a staircase tracking algorithm \[[@pone.0143994.ref050]\] functioning as follows. The stop-signal delay was set to 140 ms initially. After a successful inhibition the stop-signal delay was increased by 10 ms (making the inhibition harder). After an inhibitory failure the stop-signal delay was reduced by 10 ms (making inhibition easier). This procedure was applied to yield an inhibition rate of 50%.

We computed the stop-signal reaction time (SSRT) \[[@pone.0143994.ref049]\] by subtracting the participant's mean stop-signal delay from the median reaction time of correct go responses. Each stimulus array was presented in the middle of the screen. Stimulus duration was 300 ms and the stimulus onset asynchrony was fixed to 900 ms. Participants received at least 20 training trials to get acquainted to the task. They were encouraged to correct their errors in the go trials as fast as possible, even though no performance feedback was given to participants. The experiment was divided into 55 blocks, each comprising 20 trials, resulting in a total of 1100 trials. After each block, a rest period of 13 seconds was included.

Electrophysiological Recording {#sec011}
------------------------------

The electroencephalographic (EEG) activity was recorded continuously (digitized with a sampling rate of 250 Hz, high-pass band at 0.01 Hz, notch filter) using SYNAMP Neuroscan amplifiers from 28 tin electrodes, mounted in an elastic cap and located at standard positions (FP1/2, F3/4, C3/4, P3/4, FCz, T3/4, F7/8, T5/6, Fz, Cz, Pz, FC1/2, FC5/6, CP1/2, CP5/6, PO1/2). The EEG was referenced on-line to the right ocular canthus. Biosignals were re-referenced offline to the mean of the activity at the two mastoid processes and high-pass filtered at 1 Hz. Electrode impedances were kept below 5 kΩ. Vertical eye movements were monitored by an electrode placed below the right eye. Finally, the SOBI algorithm proposed in Joyce et al. \[[@pone.0143994.ref051]\] was used to automatically remove eye movements and blink artifacts.

Data analysis {#sec012}
-------------

In the behavioral and ERP analyses, exceptionally slow (2.5 SD) and fast (\<120 ms) reaction time (RT) responses were not included to the analysis, with no group differences on the percentage of removed trials \[Control: 2.57 ± .72%, SI-BPD: 2.31 ± .56%, and NI-BPD: 2.81 ± .81%; *F*(2,48) = 2.087, *p* = .135\]. The included behavioral data was decomposed in different variables. Two groups of variables were reported; on one hand the RTs, for correct and error responses, for compatible correct and incompatible correct responses, together with the post-error-slowing and the stop-signal RT. On the other hand, different percentages were reported: the percentage of correct and error trials, taking account all the included behavioral go-trials; the percentage of compatible correct and incompatible correct, taking account the total included in each condition, respectively; the total of inhibited and non-inhibited, taking account all the included behavioral stop-trials; and finally; the percentage of corrected errors on the total of included behavioral errors was reported. Each variable dependent variable was submitted to a one-way ANOVA with Group (Controls, SI-BPD, NI-BPD) as a 3-level factor. [Table 3](#pone.0143994.t003){ref-type="table"} contains descriptive and statistical information of the behavioral data.

10.1371/journal.pone.0143994.t003

###### Flanker Task Behavioral results.

![](pone.0143994.t003){#pone.0143994.t003g}

                             Controls (N = 17)   SI-BPD (N = 17)   NI-BPD (N = 17)   Group effect                            
  -------------------------- ------------------- ----------------- ----------------- -------------- -------- ------- ------- ------
  **RT (*ms*.*)***                                                                                                           
      Correct                450.73              63.19             483.24            65.63          468.99   50.43   1.249   .296
      Error                  319.60              39.99             330.47            48.09          361.00   64.42   2.914   .064
      Compatible Correct     433.80              60.39             464.46            69.57          456.23   53.88   1.127   .332
      Incompatible Correct   462.33              65.77             496.41            64.04          478.16   49.16   1.368   .264
      Post-error-slowing     41.03               25.53             23.51             36.09          31.54    34.48   1.248   .296
      SSRT                   297.09              58.79             328.50            66.98          316.48   50.67   1.219   .305
  **Response (%)**                                                                                                           
      Total Correct          95.76               4.60              95.48             3.12           94.01    5.83    .695    .504
      Total Error            4.25                4.60              4.52              3.12           5.99     5.83    .695    .504
      Compatible Correct     97.23               3.34              97.35             2.31           96.88    4.37    .086    .917
      Incompatible Correct   94.93               5.69              94.17             4.01           92.03    8.07    1.019   .369
      Inhibited              38.17               22.00             37.27             14.58          38.79    15.01   .032    .969
      Non-Inhibited          61.80               21.98             62.71             14.55          61.13    15.08   .035    .966
      Corrected errors       56.13               36.43             64.37             30.06          57.13    30.29   .328    .722

Notes. Means of Reaction times (RT; for each condition, post-error-slowing and SSRT) and of percentage of Responses, in the performance of the Flanker Task. Data are depict for each group, and can be observer the corresponding ANOVA with associated P values.

ERP averages were also obtained for the different conditions (time-range from -400 to 600 ms for response-locked ERPs), with a baseline of 50 ms before the button press. Epochs exceeding ±100 μV in electrooculogram (EOG) or EEG were removed from further analysis. Importantly, no group differences were found regarding the total of rejected epochs \[Control: 5.25 ± 7.51%, SI-BPD: 11.02 ± 15.36%, and NI-BPD: 8.61 ± 12.45%; *F*(2,48) = .957, *p* = .391\]. All artifact-free error trials were included regardless of a subsequent corrective response. As previous studies have shown that both choice--errors and stop-errors present similar EEG responses both in normal \[[@pone.0143994.ref052]\] and in clinical \[[@pone.0143994.ref053]\] population, we combined the choice-errors and stop-errors together in the ERP analysis in order to increase the number of error trials.

Repeated-measures ANOVAs with Condition (compatible, incompatible), Electrode location (Fz, Cz, Pz) and Response (correct, incorrect), as within-subject factors and Group (Control, SI-BPD and NI-BPD) as between-subject factors were performed using the Greenhouse-Geisser epsilon correction as appropriate \[[@pone.0143994.ref054]\]. The corrected *P*-value is reported. Finally, to discard possible effects of medication, a Pearson's correlation analysis was carried out between the Medication Load scale and the amplitude of ERN and Pe components, and also the theta band of Time-Frequency.

Time-Frequency of the electrical activity elicited by the errors and the correct responses were generated (epochs comprising 4000 ms; 2000 ms before and after the response). Epochs exceeding ±100 μV in EOG or EEG were removed from further analysis. Baseline was the 100 ms prior the button press. Single trial data was convoluted using a 7-cycles complex Morlet wavelet \[[@pone.0143994.ref055]\]. Changes in time varying energy (square of the convolution between wavelet and signal) in the studied frequencies (from 1Hz to 40Hz; linear increase) with respect to baseline were computed for each trial and averaged for each subject before performing a grand average.

Results {#sec013}
=======

Psychometric results {#sec014}
--------------------

The psychometric results are depicted in [Table 1](#pone.0143994.t001){ref-type="table"}. As it shows, the SI-BPD group obtained a higher overall score than the NI-BPD group in the diagnostic interview (DIB-R). Congruently, the severity indices showed higher severity (CGI-BPD) and less functionality (GAF) of SI-BPD than NI-BPD group. Contrarily, both groups did not show statistical differences in current depressive symptoms (HDRS) or in the self-reported measures of clinical state (BSL-23) and impulsivity (BIS-11).

Behavioral results {#sec015}
------------------

Behavioral data details were depicted in [Table 3](#pone.0143994.t003){ref-type="table"}. Participants responded faster to compatible (451.50 ± 61.77 ms) than to incompatible (478.97 ± 60.56 ms) trials \[main effect of Condition, *F*(1,48) = 160.622, *p* \< .001, *Ƞ* ^2^ = .770\]. Importantly, no significant differences were found between groups \[Group: *F*(2,48) = 1.235, *p* = .300, *Ƞ* ^2^ = .049; Condition x Group: *F*(2,48) = 1.841, *p* = .170, *η* ^*2*^ = .071; Figure A in [S1 File](#pone.0143994.s001){ref-type="supplementary-material"}\].

No statistical differences were found between groups in the percentages of correct trials and correction after errors (F\<1.7). Furthermore, importantly, no SSRT differences were found between groups. In consequence, the three groups were showed very similar in their behavioral performance in the Flanker task (for a visual analyses see Figure A in [S1 File](#pone.0143994.s001){ref-type="supplementary-material"}).

Response-locked ERP data {#sec016}
------------------------

Errors led to an increased negativity peaking about 50 ms after the error (see Figs [1](#pone.0143994.g001){ref-type="fig"} and [2](#pone.0143994.g002){ref-type="fig"}), which was identified as the ERN component, with a clear fronto-central scalp distribution in all groups \[[@pone.0143994.ref018],[@pone.0143994.ref022]\]. A repeated measures ANOVA (rmANOVA) including Group (Control, SI-BPD and NI-BPD) as a between-subject factor and Response (Correct *vs*. Error) and central Electrodes (Fz, Cz, and Pz) as within-subjects factors (mean amplitude measured at the time-window 30--80 ms) was performed. The increased negativity after errors, that characterizes the ERN component, was confirmed by the significant main effect of the Response \[*F*(1,48) *=* 43.15, *p* \< .001, *Ƞ* ^2^ = .473\]. However, unexpectedly considering previous findings in the literature, no significant group differences were observed \[Group: *F*(2,48) *=* .364, *p* = .697, *Ƞ* ^2^ = .015; Response x Group: *F*(2,48) *=* .416, *p* = .662, *Ƞ* ^2^ = .017\]. [Fig 3](#pone.0143994.g003){ref-type="fig"} shows the distribution of the ERN values for all the subjects of the three groups. As can be seen, the distribution in the three groups is very similar.

![Grand average of response-locked ERPs at Fz, Cz, Pz and EOG electrodes for controls, SI-BPD and NI-BPD individuals.\
Correct trials are depicted in blue solid lines, and choice/stop-error trials in red lines. Data were low-pass filtered at 12 Hz for illustration purposes.](pone.0143994.g001){#pone.0143994.g001}

![(A) Topography for error *vs* correct for the time window 20--70 ms (maximum and minimum values in microvolts are -3.5 and +3.5). (B) Differences waveform for the grand average between the error and correct trials, at Cz electrode, for controls (blue solid line), SI-BPD (hard green line), and NI-BPD (light green line) individuals. (C) Topography for error *vs* correct for the time window 170--270 ms, maximum and minimum values in microvolts are -6.0 and +6.0.](pone.0143994.g002){#pone.0143994.g002}

![Mean amplitude distribution of the ERN and Pe for each participant, divided into the three groups of study (Controls, SI-BPD, NI-BPD).\
A clear overlapping of distributions can be seen.](pone.0143994.g003){#pone.0143994.g003}

The Pe ERP component peaked around 200 ms (Figs [2](#pone.0143994.g002){ref-type="fig"} and [3](#pone.0143994.g003){ref-type="fig"}).We conducted the same rmANOVA analysis as for the ERN using the mean amplitude measured at the time-window 185--265 milliseconds. The Pe was associated with errors trials as shown by a Response main effect \[*F*(1,48) *=* 81.9, *p* \< .001, *Ƞ* ^2^ = .631\]. Visual inspection suggested a reduction of the Pe in SI-BPD group compared to the Control group and the NI-BPD group. However, no significant main effect of Group \[*F*(2,48) *=* .9, *p* = .41, *Ƞ* ^2^ = .036\] nor interaction Response x Group \[*F*(2,48) *=* .48, *p* = .622, *Ƞ* ^2^ = .02\] were found, showing no differences between groups in this ERP component. As can be observed in Figs [1](#pone.0143994.g001){ref-type="fig"} and [2](#pone.0143994.g002){ref-type="fig"}, the amplitude of the Pe component considering the previous ERN peak seems to be reduced in BPDs groups, especially in the SI-BPD group. Nevertheless, we calculated the difference in amplitude between the ERN and the Pe peaks in the error trials for all subjects at Cz electrode, and discarded a reduced ERN-Pe amplitude for BPDs by means of an ANOVA analysis with Group as single factor \[*F*(2,48) *=* 1.009, *p* = .372, *Ƞ* ^2^ = .04\]. [Fig 3](#pone.0143994.g003){ref-type="fig"} also shows the distribution of Pe amplitudes for the three groups.

In order to discard the effect of excess eye movement activity which could contaminate the results, we applied an rmANOVA in the EOG electrode. Ocular electrodes showed no significant differences between conditions in the ERN time range \[*F*(1,48) = .160, *p* = .691, *Ƞ* ^2^ = .003\], but significant differences between conditions in the Pe time range \[*F*(1,48) = 7.742, *p* = .008, *Ƞ* ^2^ = .139\]. However, neither the ERN \[Group *F*(2,48) *=* 1.354, *p* = .268, *Ƞ* ^2^ = .053; Response x Group *F*(2,48) *=* 1.889, *p* = .162, *Ƞ* ^2^ = .073\] nor the Pe time range \[Group *F*(2,48) *=* .513, *p* = .602, *Ƞ* ^2^ = .021; Response x Group *F*(2,48) *=* .269, *p* = .765, *Ƞ* ^2^ = .011\] showed significant effect of group, ruling out the possibility of a differential effect of eye movements in the data.

Finally, in order to discard the possibility of significant differences existing between groups in the ERPs of different frequency domains \[[@pone.0143994.ref056]\] we repeated the same analysis filtering the data to delta (1--3 Hz) and theta (3--9 Hz) frequency bands ([Fig 4A](#pone.0143994.g004){ref-type="fig"}). The rmANOVA revealed neither significant differences between groups \[(SI-BPD, NI-BPD, Control) and (BPD, Controls)\] nor congruently with non-filtered results (see supplementary results for details in [S1 File](#pone.0143994.s001){ref-type="supplementary-material"}).

![(A) Grand average of response-locked ERPs at Cz electrode, filtered for delta activity (3hz low pass), and for theta activity (3-9hz band pass), for controls, SI-BPD and NI-BPD individuals. Correct trials are depicted in blue solid lines and error trials in red lines. Scalp distribution for theta (3--9 Hz band pass filter) error activity were calculated for the two time windows (ERN and Pe), maximum and minimum values in microvolts are -4.0 and +4.0. (B) Grand average of spectral power modulation for the error trials at Cz electrode.](pone.0143994.g004){#pone.0143994.g004}

Time-Frequency: response-locked data {#sec017}
------------------------------------

In order to study the effects in the power of theta band associated with error execution (see [Fig 4B](#pone.0143994.g004){ref-type="fig"}), a rmANOVA including Group (Control, SI-BPD, NI-BPD) as a between-subject factor and Response (correct vs. error responses) and central Electrodes (Fz, Cz, and Pz) as within-subjects factors (mean amplitude measured at the time-window 50--250 ms) was performed. The significant main effect of Response \[*F*(1,42) = 178.7, *p* \< .001, *Ƞ* ^2^ = .788\] confirmed larger theta power for the error trials compared to the correct trials. As in the ERP analyses, no group differences were found between groups \[Group: *F*(2,42) = .4, *p* = .672, *Ƞ* ^2^ = .016; Response x Group: *F*(2,42) = 1.948, *p* = .154, *Ƞ* ^2^ = .075\].

Medication Load {#sec018}
---------------

No differences were found in the total number of drugs used between BPD groups \[SI- BPD group (2.59 ± 1.66); NI-BPD (2.27 ± 1.98); *t*(132) = .5, *p* = .621\]. For a more detailed description of the medication see Supplementary Material (Table A in [S1 File](#pone.0143994.s001){ref-type="supplementary-material"}).

The medication load effects were tested both for ERPs and for the theta band power of Time-Frequency. First, the correlation analysis revealed no relationship between Medication Load and ERN \[NI-BPD group (*r* = .122, *p* = .642); SI-BPD group (*r* = -.185, *p* = .476)\] nor the Pe \[NI-BPD group (*r* = .193; *p* = .457); SI-BPD group (*r* = -0.308, *p =* .229)\] components. Second, no relationship was found between the Medication Load and the theta band power of Time-Frequency \[NI-BPD group (*r* = .029, *p* = .913); SI-BPD (*r* = .048, *p* = .855)\].

Discussion {#sec019}
==========

In the present manuscript we studied whether a large sample (N = 34) of well characterized BPD patients presented an executive dysfunction in error monitoring and if this problem could be associated with non-suicidal self-injury (NSSI) behaviors. The results showed very clearly that neural signatures of error processing (ERN, Pe and theta oscillatory activity) were not altered in BPD patients compared to healthy controls. In addition, no significant differences in behavioral measures of error rates, reaction time and corrective actions after the execution of an error were found. These results are contrary to our formulated hypothesis based on previous findings \[[@pone.0143994.ref027],[@pone.0143994.ref028]\] and suggest preserved error monitoring mechanisms in BPD patients, independently of their NSSI behaviors.

Present findings contradict previous evidences which showed alteration of error monitoring in these patients when compared with healthy controls, especially a reduction in the ERN component amplitude \[[@pone.0143994.ref027],[@pone.0143994.ref028]\]. Moreover, in contrast to a previous report by Ruchsow et al. \[[@pone.0143994.ref028]\], we did not find alterations in the Pe component or reaction times in relation to control participants. Additionally, although patients self-reported higher impulsivity than control participants, the behavioral performance on the Flanker task was similar between patients and controls and no significant differences were found in the inhibitory measures related to the stop signal (SSRT and post error slowing differences). These differences regarding the two previous studies \[[@pone.0143994.ref027],[@pone.0143994.ref028]\] might be explained by the higher number of participants included in the present one (34 BPD *vs* 12 BPD patients in the two previous studies). In the same vein, the lack of alteration in error monitoring in BPD patients obtained here, is in convergence with previous inconsistent findings concerning executive functions in BPD \[[@pone.0143994.ref057]\]. These last results suggest that BPD executive functions are preserved in all sub-domains, except in working memory \[[@pone.0143994.ref058]\]. Complementarily, Hagenhoff et al. \[[@pone.0143994.ref059]\] did not find impairment in response inhibition nor error rates in BPD patients, which is also evidenced in the present paper. Thus, as proposed by others \[[@pone.0143994.ref058],[@pone.0143994.ref060]\], response inhibition deficits might not be a core aspect in BPD at least considering standard laboratory measures as for example, the stop-signal task.

A novel approach of this study was the inclusion of two groups of BPD patients, one with NSSI history and another without it. Despite BPD patients who engage in NSSI behaviors showing high clinical severity and functional impairment (in comparison with NI-BPD group, as shown in DIB-R, CGI-BPD and GAF scores), behavioral measures (except reaction time for erroneous responses), ERN and Pe amplitudes and theta power increase were similar in these two groups of patients. Thus, beyond the possible impact of NSSI behaviors in everyday life, BPD patients who self-harm, have preserved error monitoring mechanisms when compared with healthy controls and BPD patients without history of NSSI behaviors. In this same line, Janis and Nock \[[@pone.0143994.ref061]\] reported no differences in performance-based measures of impulsiveness in NSSI individuals, showing that they are, perhaps, impulsive only in certain situations. Indeed, BPD patients have shown alterations in their fronto-limbic neural activity patterns, during the performance of behavioral tasks under negative emotional induction (*e*.*g*. verbal salient stimuli in a go/no-go task, \[[@pone.0143994.ref062]\]; performing a go/no-go task after anger induction \[[@pone.0143994.ref063]\]).

Therefore, given this finding, NSSI behaviors could not be explained by a dysfunction in error monitoring. This is congruent with the idea that these behaviors respond to a variety of functions and, importantly, that not all self-injurers engaged in this behavior act impulsively and "out of control" (that is, associated with a lack of executive control: \[[@pone.0143994.ref064],[@pone.0143994.ref065]\]), but they might spend some time thinking about NSSI before engaging in it as an emotional self-regulation strategy \[[@pone.0143994.ref004],[@pone.0143994.ref008],[@pone.0143994.ref031]\]. Consequently, to understand why these complex behaviors are maintained (which is very interesting because they are not an isolated act), it is important to consider that BPD patients would incur in NSSI behaviors not as a consequence of a systematic failure in the internal error signals processing (ERN, Pe), but because their contingencies are reinforced (*e*.*g*. feel alive, stop arguing, \[[@pone.0143994.ref008]\]). This hypothesis is congruent with Linehan's biosocial theory \[[@pone.0143994.ref066]\], insomuch as the NSSI behaviors are maladaptive attempts to self-regulate negative emotional states which, in turn, are positively and/or negatively reinforced by their outcomes. It is important to notice that because of their preserved error monitoring system, the learning of alternative self-regulating strategies (more adaptive than NSSI) is possible in most BPD patients who undergo a psychological treatment \[[@pone.0143994.ref010],[@pone.0143994.ref067]\], showing that they are able to process the internal error signals adequately, in contrast to the external feedbacks \[[@pone.0143994.ref068]--[@pone.0143994.ref070]\].

The main limitation of the present study arises from the fact that BPD patients included were undergoing psychopharmacological treatment. Despite being ecologically valid, it is known that psychopharmacological compounds could play a confounding effect on the ERN \[[@pone.0143994.ref071],[@pone.0143994.ref072]\]. Importantly, we used a medication load scale which showed no relationship between behavioral and electrophysiological measures. Another potential limitation of the present data arises from uncontrolled co-morbidities, more especially ADHD which were related with deficits in executive functions \[[@pone.0143994.ref060],[@pone.0143994.ref073]\]. Finally, all participants were females and, in consequence, the present results cannot be generalized to males due to the gender differences in executive functioning \[[@pone.0143994.ref074]\] and in the ERN component \[[@pone.0143994.ref075]\].

In summary, present results show that error monitoring mechanisms are not a core aspect of BPD or NSSI behaviors. Therefore, in an attempt to self-regulate, the NSSI are not impulsive behaviors associated with the failure of a primary mechanism in performance monitoring, but with more complex interactions (*e*.*g*. information processing distortion, long lasting traits, emotional avoidance patterns). These results are encouraging because they show that BPD patients are able to detect, monitor and inhibit these behaviors. They also allow a better understanding of these complex and disabling behaviors, which are a public health concern and pose a therapeutic challenge.
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###### Relevant data which complement the findings described in manuscript.
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